
Tazopra 4000mg/500mg Injection
Marketer
Molekule India Pvt Ltd
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Tazopra 4000mg/500mg Injection
Combiflox 4000 mg/500 mg Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by healthcare providers, dosage and frequency are determined by a physician based on individual needs. Strict adherence to prescribed usage is crucial. Commonly reported side effects encompass nausea, vomiting, diarrhea, and skin rashes; injection site reactions may include pain, swelling, or erythema. Persistent or worsening side effects necessitate immediate medical consultation. Prior to use, disclose any antibiotic allergies, kidney, or liver impairments to your doctor; dosage adjustments or alternative treatments may be necessary. Under medical guidance, this injection is generally considered safe for pregnant and breastfeeding individuals.
Uses of Tazopra 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Tazopra 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Tazopra 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Tazopra 4000mg/500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Tazopra 4000mg/500mg Injection works:
Tazopra 4000 mg/500 mg Injection unites piperacillin, an antibiotic, with tazobactam, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactam counters bacterial resistance mechanisms, thus bolstering piperacillin's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Tazopra 4000 mg/500 mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Tazopra, at a dosage of 4000 mg/500 mg, is typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or absent harm to offspring; despite this, data from human studies remains scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Tazopra (4000 mg/500 mg) is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing no discernible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Tazopra 4000 mg/500 mg Injection on driving ability is unknown. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCAUTION
Exercise caution when administering Tazopra 4000 mg/500 mg Injection to individuals with impaired renal function. Dosage modification of Tazopra 4000 mg/500 mg Injection may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Tazopra 4000 mg/500 mg Injection appears to pose minimal risk for individuals with hepatic impairment. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Tazopra 4000mg/500mg Injection :
Should you forget a scheduled Tazopra 4000 mg/500 mg Injection, seek your physician's advice.
Facts to Know About Tazopra 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Anti-Infective Agents |
